Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Chariot

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Oncogene|January 16, 2003
NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cellsMohamed Bentires-Alj, Veronique Barbu, Marianne Fillet, et al.
Biochemical Pharmacology|April 24, 2008
Deregulated expression of pro-survival and pro-apoptotic p53-dependent genes upon Elongator deficiency in colon cancer cellsIsabelle Cornez, Catherine Creppe, Magali Gillard, et al.
Arthritis and Rheumatism|January 11, 2005
Interleukin-6 receptor shedding is enhanced by interleukin-1beta and tumor necrosis factor alpha and is partially mediated by tumor necrosis factor alpha-converting enzyme in osteoblast-like cellsNathalie Franchimont, Cécile Lambert, Pascale Huynen, et al.
The Journal of Biological Chemistry|September 16, 2003
Cytoplasmic IkappaBalpha increases NF-kappaB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3Patrick Viatour, Sylvie Legrand-Poels, Carine van Lint, et al.
Molecular Pharmacology|February 25, 2006
Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signatureSabine Olivier, Pierre Close, Emilie Castermans, et al.
Molecular and Cellular Biology|June 16, 2010
The repressing function of the oncoprotein BCL-3 requires CtBP, while its polyubiquitination and degradation involve the E3 ligase TBLR1Aurore Keutgens, Kateryna Shostak, Pierre Close, et al.
Trends in Biochemical Sciences|March 21, 2008
Are the IKKs and IKK-related kinases TBK1 and IKK-epsilon similarly activated?Tieu-Lan Chau, Romain Gioia, Jean-Stéphane Gatot, et al.
Nature|March 27, 2012
DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongationPierre Close, Philip East, A Barbara Dirac-Svejstrup, et al.
The Biochemical Journal|December 13, 2005
TNFalpha- and IKKbeta-mediated TANK/I-TRAF phosphorylation: implications for interaction with NEMO/IKKgamma and NF-kappaB activationMarianne Bonif, Marie-Alice Meuwis, Pierre Close, et al.
The Journal of Biological Chemistry|August 3, 2012
DERP6 (ELP5) and C3ORF75 (ELP6) regulate tumorigenicity and migration of melanoma cells as subunits of ElongatorPierre Close, Magali Gillard, Aurélie Ladang, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Oncogene|January 16, 2003
NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cellsMohamed Bentires-Alj, Veronique Barbu, Marianne Fillet, et al.
Biochemical Pharmacology|April 24, 2008
Deregulated expression of pro-survival and pro-apoptotic p53-dependent genes upon Elongator deficiency in colon cancer cellsIsabelle Cornez, Catherine Creppe, Magali Gillard, et al.
Arthritis and Rheumatism|January 11, 2005
Interleukin-6 receptor shedding is enhanced by interleukin-1beta and tumor necrosis factor alpha and is partially mediated by tumor necrosis factor alpha-converting enzyme in osteoblast-like cellsNathalie Franchimont, Cécile Lambert, Pascale Huynen, et al.
The Journal of Biological Chemistry|September 16, 2003
Cytoplasmic IkappaBalpha increases NF-kappaB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3Patrick Viatour, Sylvie Legrand-Poels, Carine van Lint, et al.
Molecular Pharmacology|February 25, 2006
Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signatureSabine Olivier, Pierre Close, Emilie Castermans, et al.
Molecular and Cellular Biology|June 16, 2010
The repressing function of the oncoprotein BCL-3 requires CtBP, while its polyubiquitination and degradation involve the E3 ligase TBLR1Aurore Keutgens, Kateryna Shostak, Pierre Close, et al.
Trends in Biochemical Sciences|March 21, 2008
Are the IKKs and IKK-related kinases TBK1 and IKK-epsilon similarly activated?Tieu-Lan Chau, Romain Gioia, Jean-Stéphane Gatot, et al.
Nature|March 27, 2012
DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongationPierre Close, Philip East, A Barbara Dirac-Svejstrup, et al.
The Biochemical Journal|December 13, 2005
TNFalpha- and IKKbeta-mediated TANK/I-TRAF phosphorylation: implications for interaction with NEMO/IKKgamma and NF-kappaB activationMarianne Bonif, Marie-Alice Meuwis, Pierre Close, et al.
The Journal of Biological Chemistry|August 3, 2012
DERP6 (ELP5) and C3ORF75 (ELP6) regulate tumorigenicity and migration of melanoma cells as subunits of ElongatorPierre Close, Magali Gillard, Aurélie Ladang, et al.
Pageof 8